Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Skylake Equity Partners is a leading South Korean private equity firm specializing in buyout and growth capital investments, primarily within the technology and industrial sectors. Founded in 2006 by Dr. Chin Dae-je, the former CEO of Samsung Electronics and Minister of Information and Communication, the firm is renowned for its "techno-PE" approach that blends financial expertise with deep technological insight. While not a primary healthcare company, Skylake has maintained a significant presence in the medical technology sector, most notably through its successful investment and scaling of Medit, a global leader in 3D dental scanners. The firm focuses on middle-market companies with high growth potential, leveraging its operational background to drive value creation and global expansion. Skylake operates out of Seoul and manages multiple blind-pool funds backed by major domestic and international institutional investors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Skylake Equity Partners.